Guj. Themis Bio.

40
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE942C01045
  • NSEID: GUJTHEM
  • BSEID: 506879
INR
377.00
-4.35 (-1.14%)
BSENSE

Jun 18

BSE+NSE Vol: 1.04 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -11.20% vs 14.45% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -11.60% vs 6.93% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 58.81% vs 30.08% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -17.56% vs 2.06% in Mar 2024

Compare Profit and Loss Results of Guj. Themis Bio.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
150.00
351.00
-201.00
-57.26%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
150.00
351.00
-201.00
-57.26%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-6.00
5.00
83.33%
Raw Materials Consumed
25.00
148.00
-123.00
-83.11%
Power & Fuel Cost
26.00
18.00
8.00
44.44%
Employee Cost
11.00
56.00
-45.00
-80.36%
Operating Expenses
8.00
19.00
-11.00
-57.89%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
11.00
-11.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
5.00
-1.00
-20.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
81.00
280.00
-199.00
-71.07%
Operating Profit (PBDIT) excl Other Income
69.00
70.00
-1.00
-1.43%
Other Income
1.00
61.00
-60.00
-98.36%
Operating Profit (PBDIT)
71.00
132.00
-61.00
-46.21%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
70.00
131.00
-61.00
-46.56%
Depreciation
5.00
11.00
-6.00
-54.55%
Profit Before Taxation & Exceptional Items
65.00
120.00
-55.00
-45.83%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
65.00
120.00
-55.00
-45.83%
Provision for Tax
16.00
18.00
-2.00
-11.11%
Profit After Tax
48.00
102.00
-54.00
-52.94%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
191.00
469.00
-278.00
-59.28%
Profit Available for appropriations
240.00
572.00
-332.00
-58.04%
Appropriations
240.00
572.00
-332.00
-58.04%
Equity Dividend (%)
67%
260%
-193.00
Earnings Per Share
4.48
9.16
-4.68
-51.09%
Profit And Loss - Net Sales
Net Sales 150.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.20% vs 14.45% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 69.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.60% vs 6.93% in Mar 2024

Profit And Loss - Interest
Interest 0.36 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 58.81% vs 30.08% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 48.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -17.56% vs 2.06% in Mar 2024